Literature DB >> 2142710

Differentiation of the IL-3-dependent NFS-60 cell line and adaption to growth in macrophage colony-stimulating factor.

I Nakoinz1, M T Lee, J F Weaver, P Ralph.   

Abstract

Macrophage CSF (M-CSF) induces responsive bone marrow precursors into rapid growth and differentiation to mature macrophages. Available cell lines that depend on M-CSF for growth are well differentiated and rather adherent. We investigated the effects of M-CSF on immature myeloid cell lines as models of the marrow precursors. The murine line NFS-60 requires IL-3 for growth and also responds to granulocyte-CSF and granulocyte-macrophage-CSF. Cultures of one NFS-60 subline, when switched from IL-3 to 10% L cell conditioned media, a source of M-CSF, or purified M-CSF, frequently acquired large, adherent cells. The adherent cells grew slowly in the presence of M-CSF, in contrast to the majority population of small, round, rapidly growing cells. The large cells had properties of differentiated macrophages that were absent in the nonadherent cells. Cells with macrophage phenotype were not observed in IL-3-supported cultures over many passages. A subline was derived from NFS-60 that grew rapidly and continuously in human or murine M-CSF as round, nonadherent cells. The line, called M-NFS-60, responded well to M-CSF and IL-3, weakly to granulocyte-CSF and not at all to murine granulocyte-macrophage-CSF, IL-4, or human IL-1. A mAb to human M-CSF specifically inhibited only M-NFS-60 proliferation induced by the human growth factor, whether produced by mammalian or bacterial cells. This study shows two effects of M-CSF on the IL-3-dependent NFS-60 line. Upon first exposure to M-CSF, cells may undergo global differentiation to slowly replicating macrophages in conditions we have not been able to define. The more common effect is rapid growth of immature myeloid cells like the bone marrow precursors, but with a block to differentiation. Thus, these cells may be useful as models of M-CSF-induced differentiation, and of permanently maintained macrophage precursors.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2142710

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  Structural comparison of recombinant human macrophage colony stimulating factor beta and a partially reduced derivative using hydrogen deuterium exchange and electrospray ionization mass spectrometry.

Authors:  Y H Zhang; X Yan; C S Maier; M I Schimerlik; M L Deinzer
Journal:  Protein Sci       Date:  2001-11       Impact factor: 6.725

2.  Interleukin 34 (IL-34) cell-surface localization regulated by the molecular chaperone 78-kDa glucose-regulated protein facilitates the differentiation of monocytic cells.

Authors:  Sayaka Ogawa; Yukiko Matsuoka; Miho Takada; Kazue Matsui; Fumihiro Yamane; Eri Kubota; Shiori Yasuhara; Kentaro Hieda; Naoki Kanayama; Naoya Hatano; Hiroshi Tokumitsu; Masaki Magari
Journal:  J Biol Chem       Date:  2018-12-20       Impact factor: 5.157

3.  Expression of colony-stimulating factor 1 receptor during prostate development and prostate cancer progression.

Authors:  Hisamitsu Ide; David B Seligson; Sanaz Memarzadeh; Li Xin; Steve Horvath; Purnima Dubey; Maryann B Flick; Barry M Kacinski; Aarno Palotie; Owen N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-15       Impact factor: 11.205

4.  Inhibition of colony-stimulating-factor-1 signaling in vivo with the orally bioavailable cFMS kinase inhibitor GW2580.

Authors:  James G Conway; Brad McDonald; Janet Parham; Barry Keith; David W Rusnak; Eva Shaw; Marilyn Jansen; Peiyuan Lin; Alan Payne; Renae M Crosby; Jennifer H Johnson; Lloyd Frick; Min-Hwa Jasmine Lin; Scott Depee; Sarva Tadepalli; Bart Votta; Ian James; Karen Fuller; Timothy J Chambers; Frederick C Kull; Stanley D Chamberlain; Jeff T Hutchins
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-25       Impact factor: 11.205

5.  p56(dok-2) as a cytokine-inducible inhibitor of cell proliferation and signal transduction.

Authors:  S Suzu; M Tanaka-Douzono; K Nomaguchi; M Yamada; H Hayasawa; F Kimura; K Motoyoshi
Journal:  EMBO J       Date:  2000-10-02       Impact factor: 11.598

6.  Disulfide linkages in the in vitro refolded intermediates of recombinant human macrophage-colony-stimulating factor: analysis of the sulfhydryl alkylation of free cysteine residues by fast-atom bombardment mass spectrometry.

Authors:  M O Glocker; B Arbogast; R Milley; C Cowgill; M L Deinzer
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-21       Impact factor: 11.205

7.  A study of intermediates involved in the folding pathway for recombinant human macrophage colony-stimulating factor (M-CSF): evidence for two distinct folding pathways.

Authors:  J A Wilkins; J Cone; Z I Randhawa; D Wood; M K Warren; H E Witkowska
Journal:  Protein Sci       Date:  1993-02       Impact factor: 6.725

8.  Identification of compound D2923 as a novel anti-tumor agent targeting CSF1R.

Authors:  Ying-Qiang Liu; Ya-Nan Wang; Xiao-Yun Lu; Lin-Jiang Tong; Yan Li; Tao Zhang; Qiu-Ju Xun; Fang Feng; Yu-Zhe Chen; Yi Su; Yan-Yan Shen; Yi Chen; Mei-Yu Geng; Ke Ding; Yan-Li Li; Hua Xie; Jian Ding
Journal:  Acta Pharmacol Sin       Date:  2018-07-03       Impact factor: 6.150

9.  A screen for peptide agonists of the G-CSF receptor.

Authors:  Nadine Conzelmann; Armin Schneider
Journal:  BMC Res Notes       Date:  2011-06-15

10.  Scorpion venom peptide SPVII promotes irradiated cells proliferation and increases the expression of the IL-3 receptor.

Authors:  Yifang Qiu; Liyuan Jiang; Caixia Wang; Yan Wang; Ting Li; Baiqian Xing; Meixun Zhou; Tianhan Kong; Weihua Dong
Journal:  Cell Biosci       Date:  2013-07-08       Impact factor: 7.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.